CD36 as a target to prevent cardiac lipotoxicity and insulin resistance

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 1, 2013, Pages 71-77

  Glatz, Jan F C ^a   Angin, Yeliz ^a   Steinbusch, Laura K M ^a   Schwenk, Robert W ^a   Luiken, Joost J F P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

CD36; Insulin resistance; Lipotoxicity; Vesicle associated membrane protein

Indexed keywords

CD36 ANTIBODY; CD36 ANTIGEN; CELLUBREVIN; EP 80317; FATTY ACID ESTER; GLUCOSE TRANSPORTER 4; HEXAPEPTIDE; HEXARELIN; MONOCLONAL ANTIBODY; SULFO N SUCCINIMIDYL OLEATE; SYNAPTOBREVIN; SYNAPTOBREVIN 4; SYNAPTOBREVIN 7; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL MODEL; CARDIAC LIPOTOXICITY; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; DRUG MECHANISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEASIBILITY STUDY; HEART MUSCLE FIBER MEMBRANE; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; LIPID DIET; LIPOTOXICITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SUBCELLULAR RECYCLING;

ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; DIABETIC CARDIOMYOPATHIES; HEART; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOTROPIC AGENTS; MEMBRANE TRANSPORT MODULATORS; MOLECULAR TARGETED THERAPY; MYOCARDIUM;

EID: 84872038479     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.04.009     Document Type: Article

References (37)

1. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 2005, 85:1093-1129.
2. Kelly D.P., Strauss A.W. Inherited cardiomyopathies. N. Engl. J. Med. 1994, 330:930-932.
3. Unger R.H., Clark G.O., Scherer P.E., Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biohys. Acta 2010, 1801:209-214.
4. Dirkx E., Schwenk R.W., Glatz J.F.C., Luiken J.J.,F.P., van Eys G.J.J.M. High fat diet induced diabetic cardiomyopathy. Prostagl. Leukotr. Essent. Fatty Acids 2011, 85:219-225.
5. Glatz J.F.C., Luiken J.J.F.P., Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: Implications for metabolic disease. Physiol. Rev. 2010, 90:367-417.
6. Abumrad N.A., El-Maghrabi M.R., Amri E.-Z., Lopez E., Grimaldi P. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 1993, 268:1993.
7. van Nieuwenhoven F.A., Verstijnen C.P.H.J., Abumrad N.A., Willemsen P.H.M., van Eys G.J.J.M., van der Vusse G.J., Glatz J.F.C. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem. Biophys. Res. Commun. 1995, 207:747-752.
8. Febbraio M., Silverstein R.L. CD36: implications in cardiovascular disease. Int. J. Biochem. Cell Biol. 2007, 39:2012-2030.
9. Habets D.D., Coumans W.A., Voshol P.J., den Boer M.A., Febbraio M., Bonen A., Glatz J.F.C., Luiken J.J.F.P. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem. Biophys. Res. Commun. 2007, 355:204-210.
10. Tanaka T., Nakata T., Oka T., Ogawa T., Okamoto F., Kusaka Y., Sohmiya K., Shimamoto K., Itakura K. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J. Lipid Res. 2001, 42:751-759.
11. Luiken J.J.F.P., Koonen D.P.Y., Willems J., Zorzano A., Fischer Y., van der Vusse G.J., Bonen A., Glatz J.F.C. Insulin stimulates long-chain fatty acid uilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 2002, 51:3113-3119.
12. van Oort M.M., van Doorn J.M., Bonen A., Glatz J.F.C., van der Horst D.J., RodenburgKW K.W., Luiken J.J.F.P. Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. Biochim. Biophys. Acta 1781, 2008:61-71.
13. Lally J.S., Jain S.S., Snook L.A., Glatz J.F.C., Luiken J.J.F.P., McFarlan J., Holloway G.P., Bonen A. Caffeine-stimulated fatty acid oxidation is blunted in CD36 null mice. Acta Physiol. 2012, 205:71-81.
14. Chabowski A., Gorski J., Luiken J.J.F.P., Glatz J.F.C., Bonen A. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77:345-353.
15. Storch J., McDermott L. Structural and functional analysis of fatty acid-binding proteins. J. Lipid. Res. 2009, 50:S126-S131.
16. Storch J., Thumser A.E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 2010, 285:32679-32683.
17. M. Kazantzis, A. Stahl, Fatty acid transport proteins, implications in physiology and disease, Biochim. Biophys. Acta, in press.
18. Chabowski A., Coort S.L.M., Calles-Escandon J., Tandon N.N., Glatz J.F.C., Luiken J.J.F.P., Bonen A. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett. 2005, 579:2428-2432.
19. Ouwens D.M., Diamant M., Fodor M., Habets D.D., Pelsers M.M.A.L., El Hanaoui M., Dang Z.C., van den Brom C.E., Vlasblom R., Rietdijk A., Boer C., Coort S.L.M., Glatz J.F.C., Luiken J.J.F.P. Cardiac contractile dysfunction in insulin-resistant rats fed a high fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 2007, 50:1938-1948.
20. Bonen A., Parolin M.L., Steinberg G.R., Calles-Escandon J., Tandon N.N., Glatz J.F.C., Luiken J.J.F.P., Heigenhauser G.J.F., Dyck D.J. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 2004, 18:1144-1146.
21. Aguer C., Mercier J., Man C.Y., Metz L., Bordenave S., Lambert K., Jean E., Lantier L., Bounoua L., Brun J.F., Raynaud de Mauverger E., Andreelli F., Foretz M., Kitzmann M. Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients. Diabetologia 2010, 53:1151-1163.
22. Holloway G.P., Benton C., Mullen K.L., Yoshida Y., Snook L.A., Han X.X., Glatz J.F.C., Luiken J.J.F.P., Lally J., Dyck D.J., Bonen A. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E738-E747.
23. Yang J., Sambandam N., Han X., Gross R.W., Courtois M., Kovacs A., Febbraio M., Finck B.N., Kelly D.P. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ. Res. 2007, 100:1208-1217.
24. Steinbusch L.K.M., Luiken J.J.F.P., Vlasblom R., Chabowski A., Hoebers N.T.H., Coumans W.A., Vroegrijk I.O.C.M., Voshol P.J., Ouwens D.M., Glatz J.F.C., Diamant M. Absence of the fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am. J. Physiol. Endocriol. Metab. 2011, 301:E618-E627.
25. Kusaka Y., Tanaka T., Okamoto F., Terasaki F., Matsunaga Y., Miyazaki H., Kawamura K. Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy. J. Mol. Cell. Cardiol. 1995, 27:1605-1612.
26. Coort S.L.M., Willems J., Coumans W.A., van der Vusse G.J., Bonen A., Glatz J.F.C., Luiken J.J.F.P. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol. Cell. Biochem. 2002, 239:213-219.
27. Bodart V., Febbraio M., Demers A., McNicoll N., Pohankova P., Perreault A., Sejlitz T., Escher E., Silverstein R.L., Lamontagne D., Ong H. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ. Res. 2002, 90:844-849.
28. Marleau S., Harb D., Bujold K., Avallone R., Iken K., Wang Y., Demers A., Sirois M.G., Febbraio M., Silverstein R.L., Tremblay A., Ong.H. EP80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J. 2005, 19:1869-1871.
29. Greenwalt D.E., Scheck S., Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 1995, 96:1382-1388.
30. Bertrand L., Ginion A., Beauloye C., Hebert A.D., Guigas B., Hue L., Vanoverschelde J.L. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via activation of protein kinase B. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H239-H250.
31. Haim T.E., Wang W., Flagg T.P., Tones M.A., Bahinski A., Numann R.E., Nichols C.G., Nerbonne J.M. Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents. J. Mol. Cell Cardiol. 2010, 48:395-405.
32. Thong F.S., Dugani C.B., Klip A. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiol. 2005, 20:271-284.
33. Jahn R., Scheller R.H. SNAREs - engines for membrane fusion. Nat. Rev. Cell Biol. 2006, 7:631-643.
34. Kawanishi M., Tamori Y., Okazawa H., Araki S., Shinoda H., Kasuga M. Role of SNAP23 in insulin-induced translcoation of GLUT4 in 3T3-L1 adipocytes. Mediation of complex formation between syntaxin4 and VAMP2. J. Biol. Chem. 2000, 275:8240-8247.
35. Schwenk R.W., Dirkx E., Coumans W.A., Bonen A., Klip A., Glatz J.F.C., Luiken J.J.F.P. Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 2010, 53:2209-2219.
36. Pohl J., Ring A., Korkmaz U., Ehehalt R., Stremmel W. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol. Biol. Cell 2005, 16:24-31.
37. Lauzier B., Merlen C., Vaillant F., McDuff J., Bouchard B., Beguin P.C., Dolinsky V.W., Foisy S., Villeneuve L.R., Labarthe F., Dyck J.R.B., Allen B.G., Charron G., Des Rosiers C. Post-translcational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J. Mol. Cell Cardiol. 2011, 51:99-108.